Page last updated: 2024-08-24

fenproporex and Obesity

fenproporex has been researched along with Obesity in 7 studies

*Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). [MeSH]

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Correr, CJ; Fernandez-Llimos, F; Lucchetta, RC; Otuki, MF; Pontarolo, R; Radominski, RB; Riveros, BS1
Boguszewski, CL; Cunha, DR; do Desterro de Figueiredo, M; dos Santos, CM; Radominski, R; Suplicy, H1
de Oliveira, AC; Paumgartten, FJ; Pereira, SS1
Cardoso, MR; Ferreira, GK; Gomes, LM; Jeremias, IC; Martinello, OB; Morais, MO; Quevedo, J; Rezin, GT; Streck, EL; Valvassori, SS1
de los Angeles Saavedra, M; Hernández, A1
Autissier, N; Dumas, P; Loireau, A; Michel, R1
Boguszewski, CL; De Almeida, SM; Niclewicz, PA; Radominski, RB; Rodrigues, AM; Suplicy, Hde L1

Reviews

1 review(s) available for fenproporex and Obesity

ArticleYear
Safety and efficacy of fenproporex for obesity treatment: a systematic review.
    Revista de saude publica, 2016, Volume: 50

    Topics: Amphetamine; Amphetamines; Anti-Obesity Agents; Humans; Obesity; Placebos

2016

Trials

2 trial(s) available for fenproporex and Obesity

ArticleYear
A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.
    International journal of obesity (2005), 2014, Volume: 38, Issue:8

    Topics: Adult; Amphetamines; Anti-Obesity Agents; Body Mass Index; Brazil; Cyclobutanes; Diet, Reducing; Diethylpropion; Female; Fluoxetine; Follow-Up Studies; Humans; Mazindol; Obesity; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Weight Loss

2014
The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:4

    Topics: Adolescent; Adult; Amphetamines; Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Humans; Lactones; Leptin; Middle Aged; Obesity; Orlistat; Weight Loss

2002

Other Studies

4 other study(ies) available for fenproporex and Obesity

ArticleYear
Diethylpropion and mazindol: An end to the discussion?
    Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:3

    Topics: Amphetamines; Appetite Depressants; Brazil; Cyclobutanes; Diethylpropion; Drug Approval; Humans; Mazindol; Obesity; Risk Assessment; Treatment Outcome

2017
Brain energy metabolism is activated after acute and chronic administration of fenproporex in young rats.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2011, Volume: 29, Issue:8

    Topics: Adolescent; Adult; Amphetamines; Animals; Brain; Central Nervous System Stimulants; Child; Citrate (si)-Synthase; Citric Acid Cycle; Creatine Kinase; Electron Transport; Energy Metabolism; Humans; Malate Dehydrogenase; Male; Obesity; Rats; Rats, Wistar; Succinate Dehydrogenase

2011
[Short-term treatment of obesity: comparison between anorexigens and behavior modification].
    Revista medica de Chile, 1984, Volume: 112, Issue:2

    Topics: Adult; Amphetamines; Appetite Depressants; Behavior Therapy; Body Weight; Diet, Reducing; Female; Humans; Middle Aged; Obesity

1984
Thyroid status and effects of 3,5,3' triiodothyroacetic acid and fenproporex in genetically lean and obese female rats.
    Biochemical pharmacology, 1980, Jun-01, Volume: 29, Issue:11

    Topics: Amphetamines; Animals; Appetite Depressants; Body Weight; Eating; Female; Lipids; Obesity; Rats; Thyroid Gland; Thyroid Hormones; Triiodothyronine

1980